Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis.

Saved in:
Bibliographic Details
Title: Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis.
Authors: Torkildsen Ø; Neuro-SysMed, Department of Neurology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Medicine, University of Bergen, Bergen, Norway., Brustad HK; Oslo Center for Biostatistics and Epidemiology, Oslo University Hospital, Oslo., Høgestøl EA; Institute of Clinical Medicine, University of Oslo, Oslo.; Department of Neurology, Oslo University Hospital, Oslo., Alstadhaug KB; Department of Neurology, Nordland Hospital Trust, Bodø, Norway., Bhan A; Department of Neurology, Stavanger University Hospital, Stavanger, Norway., Flemmen HØ; Department of Neurology, Telemark Hospital Trust, Skien, Norway., Habbestad A; Neuro-SysMed, Department of Neurology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Medicine, University of Bergen, Bergen, Norway., Høglund RAA; Department of Neurology, Akershus University Hospital, Oslo.; Institute of Basic Medical Sciences, University of Oslo, Oslo., LeBlanc M; Oslo Center for Biostatistics and Epidemiology, University of Oslo, Oslo.; Department of Method Development and Analytics, Norwegian Institute of Public Health, Oslo., Lopen P; Department of Neurology, Nord-Trøndelag Hospital Trust, Namsos, Norway., Lorentzen ÅR; Institute of Clinical Medicine, University of Oslo, Oslo.; Department of Neurology, Sørlandet Hospital Trust, Kristiansand, Norway., Morsund ÅH; Department of Neurology, Møre og Romsdal Hospital Trust, Molde, Norway., Lossius A; Department of Neurology, Akershus University Hospital, Oslo.; Institute of Basic Medical Sciences, University of Oslo, Oslo., Lundby R; Department of Neurology, Oslo University Hospital, Oslo.; Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo., Nygaard GO; Institute of Clinical Medicine, University of Oslo, Oslo.; Department of Neurology, Oslo University Hospital, Oslo., Rød BE; Neuro-SysMed, Department of Neurology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Medicine, University of Bergen, Bergen, Norway., Simonsen CS; Department of Neurology, Vestre Viken Hospital Trust, Drammen, Norway., Steffensen L; Department of Neurology, University Hospital North Norway Trust, Tromsø.; Department of Clinical Medicine, Faculty of Health Sciences, Arctic University of Norway, Tromsø., Torgauten H; Neuro-SysMed, Department of Neurology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Medicine, University of Bergen, Bergen, Norway., Piehl F; Department of Neurology, Karolinska University Hospital, Stockholm., Wergeland S; Department of Clinical Medicine, University of Bergen, Bergen, Norway.; Norwegian Multiple Sclerosis Registry and Biobank, Haukeland University Hospital, Bergen, Norway., Myhr KM; Neuro-SysMed, Department of Neurology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Medicine, University of Bergen, Bergen, Norway.
Corporate Authors: OVERLORD-MS Investigators
Source: The New England journal of medicine [N Engl J Med] 2026 Jul 02; Vol. 395 (1), pp. 44-53.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study; Comparative Study; Equivalence Trial
Journal Info: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1533-4406
DOI:10.1056/NEJMoa2600993